Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant pemetrexed + cisplatin versus vinorelbine + cisplatin in resected NSCLC
2005-004840-30Phase 2Completed
- Sponsor
- Thoraxklinik am Universitätsklinikum Heidelberg
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in non-small cell lung cancer (NSCLC) comparing Pemetrexed + cisplatin with Vinorelbine + cisplatin (2 arms). Primary endpoint: Clinical feasibility rate. Started Apr 2006; status: completed.
02
Drugs
pemetrexedcisplatinvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2005-004840-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004840-30.